m+Medelevator.RU
← Поиск публикаций
Obesity surgery · 2026

The Impact of Metabolic Bariatric Surgery on the Incidence of Breast Cancer in Patients with Obesity: A Systematic Review and Meta-Analysis.

СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Jalmood Ragad, Alsafari Walaa, Al-Asiry Hassan, Almutairi Mohammed, Alzahrani Abdullah, Alahmari Saad, Alahmadi Sara, Alalawi Ghada, Almuhaisen Mohammed, Albalawi Atheer, Alajlan Suzan, Alsannaa Noor, Alshehri Ameen

Аннотация

INTRODUCTION: Obesity is widely recognized as an important risk factor for breast cancer, largely due to its effects on hormonal regulation, chronic low-grade inflammation, and metabolic dysfunction. Metabolic bariatric surgery (MBS) produces long-term weight reduction and improves metabolic profiles, which may influence the development of obesity-related cancers. This systematic review and meta-analysis aimed to examine the relationship between bariatric surgery and breast cancer incidence in adult women with obesity.

METHODS: This review followed the PRISMA reporting standards and was registered in PROSPERO. A comprehensive search of PubMed, Google Scholar, Cochrane Library, and Web of Science was performed to identify studies comparing adult underwent metabolic bariatric surgery (MBS) with those managed without surgery. Breast cancer incidence was defined as the primary outcome. Study screening, data extraction, and quality appraisal were carried out independently by multiple reviewers. Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using a random-effects model.

RESULTS: Eight eligible studies involving 793,197 participants were included in the analysis. Among them, 140,880 women had undergone bariatric surgery, while 652,317 received non-surgical management. Women who underwent metabolic bariatric surgery demonstrated a significantly lower incidence of breast cancer compared with non-surgical controls (pooled HR 0.61; 95% CI 0.46-0.80). This risk reduction was observed in both premenopausal and postmenopausal populations.

CONCLUSION: Among women with obesity, metabolic bariatric surgery is associated with a substantially reduced risk of developing breast cancer. While these findings suggest a potential protective effect, further large- scale prospective studies are necessary to clarify causality and identify patients who may benefit most from surgical intervention.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты